In conclusion, we found that BCSS is significantly decreased among all women that develop a secondary BC compared with those with a primary BC; however, BCSS differences between secondary and primary BC are greatest for women who have hormone receptor positive disease or are of Hispanic and Asian/Pacific Islander ethnicity: groups of women who often have superior survival after primary BC. Here, NR4A1 is linked to breast cancer.